Tin tức & Cập nhật

Treatment with bimekizumab quickly relieves pain and morning stiffness among patients with axial spondyloarthritis (axSpA), as shown in a study. Such improvements persist through week 52.

In individuals with obesity and moderate-to-severe pain due to knee osteoarthritis (OA), treatment with the GLP-1 RA* semaglutide led to significantly greater reductions in body weight and pain related to knee OA as opposed to placebo, findings from the STEP** 9 trial suggest.